These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 19212960)

  • 1. Cyclic RGD-containing functionalized azabicycloalkane peptides as potent integrin antagonists for tumor targeting.
    Manzoni L; Belvisi L; Arosio D; Civera M; Pilkington-Miksa M; Potenza D; Caprini A; Araldi EM; Monferini E; Mancino M; Podestà F; Scolastico C
    ChemMedChem; 2009 Apr; 4(4):615-32. PubMed ID: 19212960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potent integrin antagonist from a small library of cyclic RGD pentapeptide mimics including benzyl-substituted azabicycloalkane amino acids.
    Arosio D; Belvisi L; Colombo L; Colombo M; Invernizzi D; Manzoni L; Potenza D; Serra M; Castorina M; Pisano C; Scolastico C
    ChemMedChem; 2008 Oct; 3(10):1589-603. PubMed ID: 18770516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and NMR structure of peptidomimetic alpha4beta7-integrin antagonists.
    Gottschling D; Boer J; Marinelli L; Voll G; Haupt M; Schuster A; Holzmann B; Kessler H
    Chembiochem; 2002 Jun; 3(6):575-8. PubMed ID: 12325015
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclic RGD peptidomimetics containing bifunctional diketopiperazine scaffolds as new potent integrin ligands.
    Marchini M; Mingozzi M; Colombo R; Guzzetti I; Belvisi L; Vasile F; Potenza D; Piarulli U; Arosio D; Gennari C
    Chemistry; 2012 May; 18(20):6195-207. PubMed ID: 22517378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biochemical evaluation of a cyclic RGD oxorhenium complex as new ligand of alphaVbeta3 integrin.
    Aufort M; Gonera M; Chaignon N; Le Clainche L; Dugave C
    Eur J Med Chem; 2009 Sep; 44(9):3394-401. PubMed ID: 19303174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic aza-peptide integrin ligand synthesis and biological activity.
    Spiegel J; Mas-Moruno C; Kessler H; Lubell WD
    J Org Chem; 2012 Jun; 77(12):5271-8. PubMed ID: 22582818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenic effect of dual/selective alpha(5)beta(1)/alpha(v)beta(3) integrin antagonists designed on partially modified retro-inverso cyclotetrapeptide mimetics.
    Gentilucci L; Cardillo G; Spampinato S; Tolomelli A; Squassabia F; De Marco R; Bedini A; Baiula M; Belvisi L; Civera M
    J Med Chem; 2010 Jan; 53(1):106-18. PubMed ID: 20055426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functionalized cyclic RGD peptidomimetics: conjugable ligands for αvβ3 receptor imaging.
    Arosio D; Manzoni L; Araldi EM; Caprini A; Monferini E; Scolastico C
    Bioconjug Chem; 2009 Aug; 20(8):1611-7. PubMed ID: 21141806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic DGR-peptidomimetic containing a bicyclic reverse turn inducer as a selective alpha(v)beta (5) integrin ligand.
    Trabocchi A; Menchi G; Danieli E; Potenza D; Cini N; Bottoncetti A; Raspanti S; Pupi A; Guarna A
    Amino Acids; 2010 Jan; 38(1):329-37. PubMed ID: 19267182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel potent and selective alphavbeta3/alphavbeta5 integrin dual antagonists with reduced binding affinity for human serum albumin.
    Raboisson P; Manthey CL; Chaikin M; Lattanze J; Crysler C; Leonard K; Pan W; Tomczuk BE; Marugán JJ
    Eur J Med Chem; 2006 Jul; 41(7):847-61. PubMed ID: 16697080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biselectivity of isoDGR peptides for fibronectin binding integrin subtypes α5β1 and αvβ6: conformational control through flanking amino acids.
    Bochen A; Marelli UK; Otto E; Pallarola D; Mas-Moruno C; Di Leva FS; Boehm H; Spatz JP; Novellino E; Kessler H; Marinelli L
    J Med Chem; 2013 Feb; 56(4):1509-19. PubMed ID: 23362923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic RGD functionalized gold nanoparticles for tumor targeting.
    Arosio D; Manzoni L; Araldi EM; Scolastico C
    Bioconjug Chem; 2011 Apr; 22(4):664-72. PubMed ID: 21434651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological evaluation of novel cRGD-paclitaxel conjugates for integrin-assisted drug delivery.
    Pilkington-Miksa M; Arosio D; Battistini L; Belvisi L; De Matteo M; Vasile F; Burreddu P; Carta P; Rassu G; Perego P; Carenini N; Zunino F; De Cesare M; Castiglioni V; Scanziani E; Scolastico C; Casiraghi G; Zanardi F; Manzoni L
    Bioconjug Chem; 2012 Aug; 23(8):1610-22. PubMed ID: 22770429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists.
    Dechantsreiter MA; Planker E; Mathä B; Lohof E; Hölzemann G; Jonczyk A; Goodman SL; Kessler H
    J Med Chem; 1999 Aug; 42(16):3033-40. PubMed ID: 10447947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phage peptide display.
    Newton J; Deutscher SL
    Handb Exp Pharmacol; 2008; (185 Pt 2):145-63. PubMed ID: 18626602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interest of RGD-containing linear or cyclic peptide targeted tetraphenylchlorin as novel photosensitizers for selective photodynamic activity.
    Frochot C; Di Stasio B; Vanderesse R; Belgy MJ; Dodeller M; Guillemin F; Viriot ML; Barberi-Heyob M
    Bioorg Chem; 2007 Jun; 35(3):205-20. PubMed ID: 17223161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting integrins: insights into structure and activity of cyclic RGD pentapeptide mimics containing azabicycloalkane amino acids.
    Belvisi L; Bernardi A; Colombo M; Manzoni L; Potenza D; Scolastico C; Giannini G; Marcellini M; Riccioni T; Castorina M; LoGiudice P; Pisano C
    Bioorg Med Chem; 2006 Jan; 14(1):169-80. PubMed ID: 16214345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and conformational analysis of cyclotetrapeptide mimetic beta-turn templates and validation as 3D scaffolds.
    Gentilucci L; Cardillo G; Tolomelli A; De Marco R; Garelli A; Spampinato S; Spartà A; Juaristi E
    ChemMedChem; 2009 Apr; 4(4):517-23. PubMed ID: 19226499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationship studies of targeting ligands against breast cancer cells.
    Yao N; Xiao W; Meza L; Tseng H; Chuck M; Lam KS
    J Med Chem; 2009 Nov; 52(21):6744-51. PubMed ID: 19835381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aza-bicyclic amino acid carboxamides as alpha4beta1/alpha4beta7 integrin receptor antagonists.
    Dyatkin AB; Gong Y; Miskowski TA; Kimball ES; Prouty SM; Fisher MC; Santulli RJ; Schneider CR; Wallace NH; Hornby PJ; Diamond C; Kinney WA; Maryanoff BE; Damiano BP; He W
    Bioorg Med Chem; 2005 Dec; 13(24):6693-702. PubMed ID: 16112583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.